S4-16.2 – #NASHDay 2023 Theme: Step Up to NASH!
Donna Cryer shares this year’s #NASHDay theme, Step Up to NASH, while Pamela Danagher and Jörn Schattenberg offer their first takes on what makes June 8th so special.
April 15, 2023
Donna Cryer shares this year’s #NASHDay theme, Step Up to NASH, while Pamela Danagher and Jörn Schattenberg offer their first takes on what makes June 8th so special.
Donna Cryer describes Global Liver Institute’s journey of growing #NASHDay over the last six years and strengthening its impact on fighting fatty liver with an engaged global community.
As a momentous year for NASH unfolds, the Surfers (Donna Cryer, Pam Danagher, Jörn Schattenberg and Roger Green) preview #NASHDay 2023 and discuss what activities and energies are leading up to the event.
Co-hosts Jörn Schattenberg and Roger Green review the 2023 Liver Forum with Executive Director Veronica Miller and speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. In this final conversation, the group shares takeaways from the published slides that they feel will be worth reviewing for those who couldn’t join the meeting live.
Co-hosts Jörn Schattenberg and Roger Green review the 2023 Liver Forum with Executive Director Veronica Miller and speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. In this conversation, the group revisits a perspective-shifting session titled “A New Look at Statistics.”
Co-hosts Jörn Schattenberg and Roger Green review Liver Forum 14 with Executive Director Veronica Miller and speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. For this conversation, each panelist picks a session that captured their interest and Mazen provides a flavor of his talk on Compensated Cirrhosis Risk Stratification.
Co-hosts Jörn Schattenberg and Roger Green review Liver Forum 14 with Executive Director Veronica Miller and speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. In this conversation, Veronica recaps the aims of the Forum and each panelist shares their initial reactions around what makes the meeting special.
Co-hosts Jörn Schattenberg, Louise Campbell and Roger Green convene to discuss what’s happening for fatty liver so far in 2023 and moving into the second quarter. In this final conversation, the group share their interests around what’s to come for the second quarter in Fatty Liver.
Co-hosts Jörn Schattenberg, Louise Campbell and Roger Green convene to discuss what’s happening for fatty liver so far in 2023 and moving into the second quarter. In this conversation, the group share thoughts around drug development and the possibility of new Phase 3 press releases on the imminent horizon. Co-hosts Jörn Schattenberg, Louise Campbell and Roger Green convene to discuss what’s happening for fatty liver so far in 2023 and moving into the second quarter. In this conversation, the group share thoughts around drug development and the possibility of new Phase 3 press releases on the imminent horizon.
Co-hosts Jörn Schattenberg, Louise Campbell and Roger Green convene to discuss what’s happening for fatty liver so far in 2023 and moving into the second quarter. In this conversation, the group discuss NICE and FibroScan in the primary care setting, frontline screening to enable early detection and prevent cirrhosis, the upcoming EASL Congress and more.